MyFinsight
Home
Blog
About
Back
Cash Flow
Indaptus Therapeutics, Inc. (INDP)
Indaptus Therapeutics, Inc. (INDP)
source: myfinsight.com
Proceeds from issuance of
shares of common stock...
$12,000,000
(195.73%↑ Y/Y)
Net cash provided by
financing activities
$11,983,819
(27.00%↑ Y/Y)
Canceled cashflow
$16,181
Net change in cash
and cash...
$6,056,185
(1532.62%↑ Y/Y)
Canceled cashflow
$5,927,634
Issuance costs
$16,181
(-95.19%↓ Y/Y)
Prepaid expenses and
other current assets
-$249,085
(69.69%↑ Y/Y)
Net cash used in
investing activities
-$4,000,000
Net cash used in
operating activities
-$1,927,634
(78.74%↑ Y/Y)
Canceled cashflow
$249,085
Purchase of short-term
investments
$4,000,000
Net loss
-$1,794,863
(81.61%↑ Y/Y)
Accounts payable and
other current...
-$317,573
(-123.81%↓ Y/Y)
Stock-based compensation
-$64,283
(-115.25%↓ Y/Y)
Back